Clinical Trial Update: A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity [Phase 2]

View source ↗

Summary

Clinical trial update showing Lilly's tirzepatide (LY3298176) is being evaluated in Phase 2 dose studies for type 2 diabetes mellitus and obesity, with the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes, Obesity | Phase 2 | Status: ACTIVE_NOT_RECRUITING